🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Context Therapeutics Inc.

CNTX Healthcare
$2.79 +$0.07 (2.57%)
Market Cap: $256.34 M
Gurus Holding
2
Popularity Rank
#3634
% of Shares Held
0.61%
Net Activity (Q4 2025)
+$354,127.08

Guru Ownership Trend

Guru Analysis for Context Therapeutics Inc. (CNTX)

Context Therapeutics Inc. (CNTX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.57 M.

Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.

Institutional sentiment is currently Bullish. This is evidenced by a $354,127.08 net inflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$354,127.08
Total Buy Value
New Buys 1
Additions 1
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
2

FAQs for Context Therapeutics Inc. (CNTX)

Major holders include Renaissance Technologies (RenTech) ($747,244), Steven Cohen ($77,470). According to the latest reported data, 2 tracked investment managers collectively hold approximately 561,030 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $354,127.08, with 2 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in CNTX during the most recent reporting period.

Yes, 1 managers opened new positions in CNTX, and 1 increased their existing holdings. The total reported buy value was $354,127.08.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 58.8% 508,329 $747,244 Q4 2025
0.00% New Buy 52,701 $77,470 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form